FDA Adverse Event Injury Summary report: N

TRULIANT TIB IMP CR INS SLOPE++ SZ 3.5 13 MM

MDR report key: 16986118 · Received May 23, 2023

Report

Report Number
1038671-2023-01084
Event Type
Injury
Date Received
May 23, 2023
Date of Event
March 1, 2021
Report Date
June 19, 2023
Manufacturer
EXACTECH, INC.
Product Code
JWH
UDI-DI
10885862307200
PMA / PMN Number
K152170
Removal / Correction Number
Z-0023-2022
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION- A2, A3, & B7 H6. INVESTIGATION RESULTS - THE TRULIANT INSERT WITH SERIAL NUMBER M008382 IS CONFIRMED TO HAVE BEEN PACKAGED IN A VACUUM BAG THAT DOES NOT CONTAIN EVOH. THE CAUSE OF THE PATIENT'S CONDITION AND REVISION SURGERY AS RELATED TO THE DEVICES CANNOT BE CONCLUSIVELY DETERMINED, INSUFFICIENT INFORMATION. THESE DEVICES ARE USED FOR TREATMENT NOT DIAGNOSIS. THERE IS NO OTHER INFORMATION.

Additional Manufacturer Narrative · 0

D10: CONCOMITANTS: 6118405 02-020-13-0235 - TRULIANT CR CEM FEM CR CEM LEFT SZ 3.5. 6433063 02-022-45-3535 - TRULIANT TIB FIT TRAY CEM SZ 3.5F / 3.5T. 6187639 200-02-29 - THREE PEG PATELLA 29MM.

Description of Event or Problem · 0

AS REPORTED VIA LEGAL DOCUMENTATION THE PATIENT HAD A LEFT KNEE REPLACEMENT IN (B)(6) 2020. APPROXIMATELY 9 MONTHS AFTER THE INITIAL PROCEDURE THE PATIENT HAD A LEFT KNEE REVISION IN (B)(6) 2021 AFTER FLUID COLLECTION. THERE IS NO OTHER PATIENT DEMOGRAPHIC OR MEDICAL HISTORY AVAILABLE. THERE IS NO INFORMATION ON THE SURGICAL PROCEDURE OR PATIENT OUTCOME. THERE IS NO DEVICE RETURN. THERE ARE NO PHOTOS OR OTHER IMAGES OF THE DEVICE PROVIDED. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1410256 TRULIANT TIB IMP CR INS SLOPE++ SZ 3.5 13 MM PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, CEMENTED, POLYMER/METAL/POLYMER JWH EXACTECH, INC. TRULIANT TIB IMP CR INS SLOPE++ SZ 3.5 13 MM UNK 10885862307200

Patients

Seq Age Sex Outcome Treatment
1 59 YR Female Required Intervention SEE H10